510(k) Market Clearance for FluChip-8G Influenza A+B Assay InDevR receives 510(k) market clearance for the first influenza diagnostic assay capable of distinguishing between seasonal and non-seasonal influenza A subtypes ...
Read More

InDevR Chosen for NIH’s Innovation Zone at BIO International Convention One of select group of NIH SBIR awardees to be featured at BIO   BOULDER COLORADO (4/9/19) — ...
Read More

[Press Release] New VaxArray Neuraminidase Potency Test for N9 InDevR launches first-in-class reagent kit for rapid quantification of N9 in  “pandemic” influenza vaccines.   BOULDER COLORADO (3/26/19) — InDevR ...
Read More

New npj Vaccines Paper on Influenza Neuraminidase Potency Open Full Publication   ...
Read More

VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines ...
Read More

[Press Release] FluChip-8G® Insight Evaluated for Enhanced Influenza Surveillance in Southeast Asia InDevR collaborating with Armed Forces Research Institute of Medical Sciences to test FluChip-8G Insight™ BOULDER (12/4/18) — InDevR ...
Read More